Ionis Pharmaceuticals Inc. is a leading biotechnology company specializing in the development and commercialization of RNA-targeted therapeutics. Their innovative approach has resulted in a diverse pipeline of potential treatments for a range of diseases, including rare genetic disorders and various types of cancer. With a strong track record of success and a focus on patient-centric research, Ionis Pharmaceuticals is well positioned to continue making a significant impact in the healthcare industry.